These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 11462017)

  • 1. Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains.
    Baribaud F; Wirth S; Maillard I; Valsesia S; Acha-Orbea H; Diggelmann H
    J Virol; 2001 Aug; 75(16):7453-61. PubMed ID: 11462017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell receptor V beta repertoire in mice lacking endogenous mouse mammary tumor provirus.
    Braun MY; Jouvin-Marche E; Marche PN; MacDonald HR; Acha-Orbea H
    Eur J Immunol; 1995 Mar; 25(3):857-62. PubMed ID: 7705418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A V beta 4-specific superantigen encoded by a new exogenous mouse mammary tumor virus.
    Maillard I; Erny K; Acha-Orbea H; Diggelmann H
    Eur J Immunol; 1996 May; 26(5):1000-6. PubMed ID: 8647159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A V beta 8.2-specific superantigen from exogenous mouse mammary tumor virus carried by FM mice.
    Yoshimoto T; Nagase H; Nakano H; Matsuzawa A; Nariuchi H
    Eur J Immunol; 1994 Jul; 24(7):1612-9. PubMed ID: 7913038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of natural killer cells by mouse mammary tumor virus C4 in BALB/c and T-cell receptor V beta 2-transgenic mice.
    Gill R; Wang H; Bluethmann H; Iglesias A; Wei WZ
    Cancer Res; 1994 Mar; 54(6):1529-35. PubMed ID: 8137259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptors on T cells escaping superantigen-mediated deletion lack special beta-chain junctional region structural characteristics.
    Pullen AM; Bogatzki LY
    J Immunol; 1996 Mar; 156(5):1865-72. PubMed ID: 8596038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New infectious mammary tumor virus superantigen with V beta-specificity identical to staphylococcal enterotoxin B (SEB).
    Luther S; Shakhov AN; Xenarios I; Haga S; Imai S; Acha-Orbea H
    Eur J Immunol; 1994 Aug; 24(8):1757-64. PubMed ID: 8056034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of two V beta 7-specific viral superantigens.
    Ignatowicz L; Kappler JW; Marrack P; Scherer MT
    J Immunol; 1994 Jan; 152(1):65-71. PubMed ID: 8254207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant infection with exogenous mouse mammary tumor virus encoding I-E-dependent superantigen in I-E-negative mouse strain.
    Ando Y; Wajjwalku W; Niimi N; Hiromatsu K; Morishima T; Yoshikai Y
    J Immunol; 1995 Jun; 154(12):6219-26. PubMed ID: 7759859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
    Simpson E; Takacs K; Altmann DM
    Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of a V beta 2-specific superantigen with a tumorigenic milk-borne mouse mammary tumor virus.
    Hodes RJ; Novick MB; Palmer LD; Knepper JE
    J Immunol; 1993 Feb; 150(4):1422-8. PubMed ID: 8094408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an endogenous mammary tumor virus involved in the clonal deletion of V beta 2 T cells.
    Jouvin-Marche E; Marche PN; Six A; Liebe-Gris C; Voegtle D; Cazenave PA
    Eur J Immunol; 1993 Nov; 23(11):2758-64. PubMed ID: 8223851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse mammary tumor virus superantigens require N-linked glycosylation for effective presentation to T cells.
    McMahon CW; Bogatzki LY; Pullen AM
    Virology; 1997 Feb; 228(2):161-70. PubMed ID: 9123822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the Mlsf system. II. Identification of mouse mammary tumor virus proviruses involved in the clonal deletion of self-Mlsf-reactive T cells.
    Foo-Phillips M; Kozak CA; Principato MA; Abe R
    J Immunol; 1992 Dec; 149(11):3440-7. PubMed ID: 1331236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of two structurally identical viral superantigens results in thymic elimination at distinct developmental stages.
    Morishima C; Norby-Slycord C; McConnell KR; Finch RJ; Nelson AJ; Farr AG; Pullen AM
    J Immunol; 1994 Dec; 153(11):5091-103. PubMed ID: 7963568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence similarity between the long terminal repeat coding regions of mammary-tumorigenic BALB/cV and renal-tumorigenic C3H-K strains of mouse mammary tumor virus.
    Kang JJ; Schwegel T; Knepper JE
    Virology; 1993 Sep; 196(1):303-8. PubMed ID: 8395120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of CD4+ T cells by mouse mammary tumor virus (FM) superantigen with broad specificity of T cell receptor beta-chain variable region.
    Yoshimoto T; Nagase H; Nakano H; Matsuzawa A; Nariuchi H
    Virology; 1996 Sep; 223(2):387-91. PubMed ID: 8806576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strain-specific expression of spliced MMTV RNAs containing the superantigen gene.
    Xu L; Wrona TJ; Dudley JP
    Virology; 1997 Sep; 236(1):54-65. PubMed ID: 9299617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of endogenous mouse mammary tumor virus superantigen expression by lymphocyte subsets.
    Waanders GA; Lees RK; Held W; MacDonald HR
    Eur J Immunol; 1995 Sep; 25(9):2632-7. PubMed ID: 7589137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new infectious mammary tumor virus in the milk of mice implanted with C4 hyperplastic alveolar nodules.
    Shakhov AN; Wang H; Acha-Orbea H; Pauley RJ; Wei WZ
    Eur J Immunol; 1993 Nov; 23(11):2765-9. PubMed ID: 8223852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.